CARDIO DIAGNOSTICS HOLDINGS INC(CDIO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CDIO CARDIO DIAGNOSTICS HOLDINGS INC

Pre-Market Trading 05-17 04:59:58 EDT

0.8390

-0.0078

-0.92%

High0.8900	Low0.8121	Vol188.16K
Open0.8725	D1 Closing0.8468	Amplitude9.20%
Mkt Cap18.11M	Tradable Cap14.82M	Total Shares21.59M
T/O158.33K	T/O Rate1.06%	Tradable Shares17.67M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"CDIO","market":"US","secType":"STK","nameCN":"CARDIO DIAGNOSTICS HOLDINGS INC","latestPrice":0.839,"timestamp":1715889600000,"preClose":0.8468,"halted":0,"volume":188156,"delay":0,"floatShares":17669567,"shares":21591119,"eps":-0.660366,"marketStatus":"Pre-Market Trading","change":-0.0078,"latestTime":"05-17 04:59:58 EDT","open":0.8725,"high":0.89,"low":0.8121,"amount":158326.25578120002,"amplitude":0.091993,"askPrice":0.9212,"askSize":100,"bidPrice":0.82,"bidSize":25,"shortable":3,"etf":0,"ttmEps":-0.660366,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1715952600000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.839,"postHourTrading":{"tag":"盘后","latestPrice":0.821,"preClose":0.839,"latestTime":"19:59 EDT","volume":2519,"amount":2102.8911,"timestamp":1715903966198},"volumeRatio":0.05638764935565675},"requestUrl":"/m/hq/s/CDIO/tweets","defaultTab":"tweets","newsList":[{"id":"2435302061","title":"Cardio Diagnostics Holdings Inc    expected to post a loss of 9 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2435302061","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2435302061?lang=en_us&edition=fundamental","pubTime":"2024-05-14 04:17","pubTimestamp":1715631427,"startTime":"0","endTime":"0","summary":"* Cardio Diagnostics Holdings Inc     is expected to report resultson May 15 (estimated) for the period ending March 31 2024   * The Chicago Illinois-based  company is expected to report revenue of $5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2435532754","title":"Cardio Diagnostics Holdings, Inc. Announces the Availability of Its Clinical Tests at Family Medicine Specialists’ Retail Healthcare Clinic at Walmart Supercenter in Round Lake Beach, Illinois, That Offers Walk-In Appointments Seven Days a Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2435532754","media":"Business Wire","top":-1,"share":"https://ttm.financial/m/news/2435532754?lang=en_us&edition=fundamental","pubTime":"2024-05-13 20:31","pubTimestamp":1715603460,"startTime":"0","endTime":"0","summary":"CHICAGO, May 13, 2024----Cardio Diagnostics Holdings, Inc. , an AI-driven precision cardiovascular medicine company, announced today that the Company’s clinical blood tests, Epi+Gen CHD and PrecisionCHD, are now available at Family Medicine Specialists’  newest clinical location at the Walmart Supercenter in Round Lake Beach, Illinois. FMS is a leading primary care and risk-bearing provider in Northern Illinois and in December 2023, launched the ongoing Heart Attack Prevention Initiative for at least 1,200 of their BlueCross BlueShield and other health plan patients. This launch in a retail healthcare setting is an expansion to existing and new patients in the area.These retail healthcare clinics are now seen as minimal care providers and vital players in the primary healthcare landscape. Innovative providers like Family Medicine Specialists are at the forefront of partnering with retail organization","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/vSVMOrST314eVC63Jd9_gA--~B/aD0yNzI7dz0xMDg2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/ef2abd64e3ce65e9024e75d452dc6784","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/vSVMOrST314eVC63Jd9_gA--~B/aD0yNzI7dz0xMDg2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/ef2abd64e3ce65e9024e75d452dc6784"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cardio-diagnostics-holdings-inc-announces-123100547.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2434895815","title":"Insider Sale: Senior Vice President & CDIO Soumya Seetharam Sells 23,291 Shares of Corning ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2434895815","media":"GuruFocus.com","top":-1,"share":"https://ttm.financial/m/news/2434895815?lang=en_us&edition=fundamental","pubTime":"2024-05-11 07:01","pubTimestamp":1715382110,"startTime":"0","endTime":"0","summary":"On May 9, 2024, Soumya Seetharam, Senior Vice President & Chief Digital and Information Officer of Corning Inc , sold 23,291 shares of the company. The transaction was documented in a recent SEC Filing. This sale is part of a pattern observed over the past year, where the insider has sold a total of 23,291 shares and made no purchases.GuruFocus has detected 10 Warning Signs with GLW.Corning Inc  specializes in materials science, with a focus on manufacturing and engineering glass, ceramics, and related materials for industrial and scientific applications. The company's products are integral to the sectors of display technology, optical communications, automotive technology, and life sciences.On the date of the sale, shares of Corning Inc were priced at $34.01, resulting in a market cap of approximately $29.27 billion. The price-earnings ratio of the company stood at 48.13, significantly above both the industry median and the company's historical median.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/upcJ8HrcFCaYq1xpxjdi8Q--~B/aD04MjY7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/bf5a473b884f56a8ff5daf19e46d658d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/upcJ8HrcFCaYq1xpxjdi8Q--~B/aD04MjY7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/bf5a473b884f56a8ff5daf19e46d658d"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/insider-sale-senior-vice-president-230150209.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426719613","title":"Exponential Health Partners with Cardio Diagnostics to Elevate Cardiovascular Disease Prevention in Michigan","url":"https://stock-news.laohu8.com/highlight/detail?id=2426719613","media":"Business Wire","top":-1,"share":"https://ttm.financial/m/news/2426719613?lang=en_us&edition=fundamental","pubTime":"2024-04-09 20:31","pubTimestamp":1712665860,"startTime":"0","endTime":"0","summary":"Exponential Health, an innovative concierge medicine practice in Michigan, adopts Cardio Diagnostics' AI-driven epigenetic-genetic tests, marking a new era in personalized and preventive cardiac care.CHICAGO, April 09, 2024----In a significant stride towards transforming cardiovascular healthcare in concierge specialty and primary care offices, Exponential Health, an innovative concierge medical practice led by Dr. William Baer, is set to offer Cardio Diagnostics Holdings, Inc.’s  clinical epigenetic-genetic cardiovascular tests, Epi+Gen CHD and PrecisionCHD, to their patients. As a result, Exponential Health is expanding access to a new chapter in the proactive management of heart disease.Exponential Health emphasizes a more personalized and patient-centric approach to preventive care. Its value-based care model allows Exponential Health to dedicate more time to each patient, conducting comprehensive assessments and creating tailored preventive care plans for them.Cardio Diagnostics' ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/iPxQjjKkPMDypcUDwe.4BA--~B/aD0yNzI7dz0xMDg2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/90bdd352205f6c633278f6fe68b77849","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/iPxQjjKkPMDypcUDwe.4BA--~B/aD0yNzI7dz0xMDg2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/90bdd352205f6c633278f6fe68b77849"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exponential-health-partners-cardio-diagnostics-123100468.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2424284318","title":"Cardio Diagnostics enters a telehealth agreement with Navierre","url":"https://stock-news.laohu8.com/highlight/detail?id=2424284318","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2424284318?lang=en_us&edition=fundamental","pubTime":"2024-04-04 22:26","pubTimestamp":1712240781,"startTime":"0","endTime":"0","summary":"Cardio Diagnostics  announced a strategic partnership with Navierre, an innovative digital health technology platform. Navierre is a consumer-centric digital health platform and the collaboration aims to significantly expand access to Cardio Diagnostics' industry-leading, AI-enabled precision cardiovascular diagnostic tests. Mustafa Dinani, CEO and Co-Founder of Navierre. \"By combining our innovative platform with their AI-driven precision diagnostics, we empower patients and clinicians with the tools they need to identify cardiovascular risk early when it can be most effectively addressed. Together, we are making significant strides in the fight against the world's leading cause of death.\"    More on Cardio Diagnostics  Seeking Alpha’s Quant Rating on Cardio Diagnostics Holdings, Inc. Historical earnings data for Cardio Diagnostics Holdings, Inc. Financial information for Cardio Diagnostics Holdings, Inc.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4087295-cardio-diagnostics-enters-a-telehealth-agreement-with-navierre","is_publish_highlight":false,"gpt_icon":0},{"id":"2424396607","title":"Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with Navierre","url":"https://stock-news.laohu8.com/highlight/detail?id=2424396607","media":"Business Wire","top":-1,"share":"https://ttm.financial/m/news/2424396607?lang=en_us&edition=fundamental","pubTime":"2024-04-04 20:31","pubTimestamp":1712233860,"startTime":"0","endTime":"0","summary":"CHICAGO, April 04, 2024----Cardio Diagnostics Holdings, Inc. , an AI-driven precision cardiovascular medicine company, announces a strategic partnership with Navierre, an innovative digital health technology platform which revolutionizes how patients access healthcare and serves as a true health companion for every stage from birth to the golden years with a robust care navigation, wellness, and chronic care management offering. This collaboration aims to significantly expand access to Cardio Diagnostics' industry-leading, AI-enabled precision cardiovascular diagnostic tests.\"We are thrilled to partner with Navierre to make our industry-leading cardiovascular clinical tests more widely available to patients and clinicians nationwide,\" said Meesha Dogan, Ph.D., CEO and Co-Founder of Cardio Diagnostics. \"Navierre's innovative platform aligns with our mission to tran","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/6JXWv5YmjbyjOZGIxTKjjA--~B/aD0yNzI7dz0xMDg2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/f35e3b4729245503cf42e6794a51b740","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/6JXWv5YmjbyjOZGIxTKjjA--~B/aD0yNzI7dz0xMDg2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/f35e3b4729245503cf42e6794a51b740"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cardio-diagnostics-holdings-inc-enters-123100244.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2424341815","title":"Cardio Diagnostics Holdings Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag","url":"https://stock-news.laohu8.com/highlight/detail?id=2424341815","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2424341815?lang=en_us&edition=fundamental","pubTime":"2024-04-03 19:00","pubTimestamp":1712142012,"startTime":"0","endTime":"0","summary":"NasdaqCM:CDIO Earnings and Revenue Growth April 3rd 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue missed analyst estimates by 88%. Earnings per share  exceeded analyst estimates by 15%.Looking ahead, revenue is forecast to grow 111% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Biotechs industry in the US.The company's shares are down 24% from a week ago.You should always think about risks. Case in point, we've spotted   6 warning signs for Cardio Diagnostics Holdings  you should be aware of, and 4 of them can't be ignored.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cardio-diagnostics-holdings-full-2023-110012344.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2424003519","title":"Cardio Diagnostics Unveils New Investor Engagement Materials","url":"https://stock-news.laohu8.com/highlight/detail?id=2424003519","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2424003519?lang=en_us&edition=fundamental","pubTime":"2024-04-03 04:42","pubTimestamp":1712090543,"startTime":"0","endTime":"0","summary":"Cardio Diagnostics Holdings (CDIO) has shared an announcement. Starting April 3, 2024, Cardio Diagnostics Holdings Inc. will use a new set of inves...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cardio-diagnostics-unveils-new-investor-engagement-materials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cardio-diagnostics-unveils-new-investor-engagement-materials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2424220040","title":"Cardio Diagnostics Holdings Inc reports results for the quarter ended in December - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2424220040","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2424220040?lang=en_us&edition=fundamental","pubTime":"2024-04-03 01:26","pubTimestamp":1712078804,"startTime":"0","endTime":"0","summary":"* Cardio Diagnostics Holdings Inc    reported quarterly breakeven results per share for the quarter ended in December, higher than the same quarter last year, when the company reported EPS of -9 cents","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2424285024","title":"XTIA, TPET and GSIT among mid-day movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2424285024","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2424285024?lang=en_us&edition=fundamental","pubTime":"2024-04-03 01:01","pubTimestamp":1712077295,"startTime":"0","endTime":"0","summary":"Gainers: VivoPower International PLC  +412%. Ashford  +105%. XTI Aerospace  +88%. Nexalin Technology  +54%. Trio Petroleum Corp.  +45%. VirTra  +36%. GSI Technology  +32%. Lobo EV Technologies Ltd.  +28%. Keyarch Acquisition Corp  +26%.  C3is  +24%.  Losers: Acorda Therapeutics  -75%. Gritstone Bio  -49%. Verve Therapeutics  -35%. Canoo  -29%. Binah Capital Group  -27%. Pioneer Power Solutions  -24%. PVH Corp  -23%. CXApp  -22%. Petros Pharmaceuticals  -21%. Cardio Diagnostics Holdings  -20%.  More on Mid-day movers & stocks.  GSI Technology: Getting Ready To Test Gemini-II, III Still Far Off GSI Technology, Inc.  Q3 2024 Earnings Call Transcript XTI Aircraft that will merge with Inpixon gets Chinese patent for an aircraft Trio Petroleum to buy 20% stake in Utah heavy oil project in $2M deal Financial information for GSI Technology","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4086509-xtia-tpet-and-gsit-among-mid-day-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2424004605","title":"Canopy Growth, Exact Sciences, Stereotaxis among healthcare movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2424004605","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2424004605?lang=en_us&edition=fundamental","pubTime":"2024-04-02 22:00","pubTimestamp":1712066425,"startTime":"0","endTime":"0","summary":"Gainers: Aditxt  +25%. Stereotaxis  +13%. Nexalin Technology  +10%. Exact Sciences  +8%. Canopy Growth  +6%.  Losers: Acorda Therapeutics  -86%. Gritstone Bio  -46%. Verve Therapeutics  -31%. Cardio Diagnostics Holdings  -19%. Petros Pharmaceuticals  -16%.  S&P 500 Health Care Sector -1.52% to 1682.8. Health Care Equipment & Services -2.64% to 1942.33. Pharmaceuticals, Biotechnology & Life Science which contributes 58% to index is -0.73% to 1383.81.  More on Health Care Select Sector SPDR  XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Eli Lilly tops S&P 500 healthcare sector in Q1 as weight loss frenzy continues Johnson & Johnson, Boston Scientific least shorted stocks in S&P 500 healthcare sector for Feb-end","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4086352-canopy-growth-exact-sciences-stereotaxis-among-healthcare-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2423109414","title":"Cardio Diagnostics Holdings Inc    expected to post a loss of 13 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2423109414","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2423109414?lang=en_us&edition=fundamental","pubTime":"2024-03-30 04:31","pubTimestamp":1711744297,"startTime":"0","endTime":"0","summary":"* Cardio Diagnostics Holdings Inc     is expected to show a rise in quarterly revenue when it reports  results on March 31 (estimated) for the period ending December 31 2023   * The Chicago Illinois-b","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2419055826","title":"Cardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology’s 73rd Annual Scientific Session","url":"https://stock-news.laohu8.com/highlight/detail?id=2419055826","media":"Business Wire","top":-1,"share":"https://ttm.financial/m/news/2419055826?lang=en_us&edition=fundamental","pubTime":"2024-03-14 20:31","pubTimestamp":1710419460,"startTime":"0","endTime":"0","summary":"CHICAGO, March 14, 2024----Cardio Diagnostics Holdings, Inc. , an AI-powered precision cardiovascular medicine company, announces that the Company will showcase its groundbreaking HeartRiskTM and Actionable Clinical IntelligenceTM platforms at the American College of Cardiology’s 73rd Annual Scientific Session , taking place in Atlanta, GA, from April 6-8, 2024. Cardio Diagnostics' mission is in lockstep with this year's ACC.24 conference theme, \"Advancing Cardiovascular Care for All.\" By harnessing cutting-edge technology at the intersection of genomics, epigenomics, and artificial intelligence, the Company is advancing precision medicine in cardiology and improving the standard of cardiovascular medicine available to patients.All attendees including providers, provider organizations and potential industry partners will be able to learn more about Cardio Diagnostics' HeartRisk and Actionable Clinical Intelligence platforms at booth 3605. The booth will feature live demonstrations and ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/TKSgjTnEuy8A2RncRgTMIQ--~B/aD0yNzI7dz0xMDg2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/1ba8c347d927d19df884e7eba889997b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/TKSgjTnEuy8A2RncRgTMIQ--~B/aD0yNzI7dz0xMDg2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/1ba8c347d927d19df884e7eba889997b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cardio-diagnostics-holdings-inc-showcase-123100315.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2417654416","title":"Cardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2417654416","media":"Business Wire","top":-1,"share":"https://ttm.financial/m/news/2417654416?lang=en_us&edition=fundamental","pubTime":"2024-03-05 21:31","pubTimestamp":1709645460,"startTime":"0","endTime":"0","summary":"Company Continues to Build and Expand the Global IP Portfolio of Its One-of-a-Kind Technology. CHICAGO, March 05, 2024----Cardio Diagnostics Holdings, Inc. , an AI-driven precision cardiovascular medicine company, announces that the U.S. Patent and Trademark Office has issued a notice of allowance to University of Iowa Research Foundation  for U.S. Application No. 17,857,723 titled Compositions and Methods for Detecting Predisposition to Cardiovascular Disease, which is exclusively licensed to the Company from UIRF, and that was co-invented by Cardio Diagnostics' founders, Meesha Dogan, Ph.D., and Robert Philibert, MD Ph.D., the Chief Executive Officer and Chief Medical Officer of the Company, respectively. This is the second U.S. patent being issued in this patent family. Patents in this patent family have also been issued in the European Union, China, India, and Australia.Among Escalating CVD Burden, Company Continues to Expand IP Portfolio. Epi+Gen CHD: An integrated genetic-epigene","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/470YoU2VeJwuMBXNNaSefA--~B/aD0yNzI7dz0xMDg2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/23fae45621d6118571f4f1b452d04c94","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/470YoU2VeJwuMBXNNaSefA--~B/aD0yNzI7dz0xMDg2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/23fae45621d6118571f4f1b452d04c94"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cardio-diagnostics-holdings-inc-announces-133100068.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2417127532","title":"JAGX, BBAI and BNTC among mid-day movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2417127532","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2417127532?lang=en_us&edition=fundamental","pubTime":"2024-03-05 01:35","pubTimestamp":1709573730,"startTime":"0","endTime":"0","summary":"Gainers:Phunware (PHUN) +133%.Ocean Biomedical (OCEA) +57%.Jaguar Health (JAGX) +54%.Energem Corp (ENCP) +47%.Ainos (AIMD) +41%.Renalytix (RNLX) +38%.Xos (XOS) +35%.BigBear.ai Holdings (BBAI) +30%.Urgent.ly (ULY) +30%.Losers: BioVie (BIVI) -42%.Astra Space (ASTR) -39%.Bit Origin Ltd (BTOG) -28%.Minim (MINM) -24%.Infobird Co Ltd (IFBD) -24%.Vivani Medical (VANI) -20%.Beamr Imaging Ltd (BMR) -19%.First Wave BioPharma (FWBI) -18%.Cardio Diagnostics Holdings (CDIO) -17%.Benitec Biopharma (BNTC) -18%.","market":"sh","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4075475-jagx-bbai-and-bntc-among-mid-day-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2411154655","title":"Cardio Diagnostics Holdings, Inc. Expands HeartRisk™ Platform Offering to Diverse Markets in Conjunction with Nationwide Rollout","url":"https://stock-news.laohu8.com/highlight/detail?id=2411154655","media":"Business Wire","top":-1,"share":"https://ttm.financial/m/news/2411154655?lang=en_us&edition=fundamental","pubTime":"2024-02-15 21:46","pubTimestamp":1708004760,"startTime":"0","endTime":"0","summary":"Transformative Cardiovascular Risk Management Solutions Extend Beyond Traditional Sectors to Include Federal and State Correctional Facilities, Broker and Benefits Organizations, and Risk Bearing Providers.CHICAGO, February 15, 2024----Cardio Diagnostics Holdings, Inc. , an AI-driven precision cardiovascular medicine company, announced today the nationwide rollout and a significant expansion of its groundbreaking HeartRisk platform. HeartRisk combines insights from HIPAA-compliant anonymized and aggregated clinical cardiovascular data obtained through Cardio Diagnostics’ Epi+Gen CHD and PrecisionCHD clinical tests, with industry and geographic data to enable real-time population-level cardiovascular disease  risk insights.Family Medicine Specialists' implementation of Cardio Diagnostics' tests in their patient population with CHD risk factors demonstrates the first time a risk-bearing provider is leveraging precision epigenetics-based heart disease technologies with a population health","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/gZQB8lnHe0.m_QvZcxTPKQ--~B/aD0yNzI7dz0xMDg2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/f4d2bf286e79ac7ade7c12e04ccce287","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/gZQB8lnHe0.m_QvZcxTPKQ--~B/aD0yNzI7dz0xMDg2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/f4d2bf286e79ac7ade7c12e04ccce287"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cardio-diagnostics-holdings-inc-expands-134600379.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2409122953","title":"Cardio Diagnostics Holdings, Inc. Expands Partnership with Family Medicine Specialists to Bring Its Specialty Cardiology Tests to Select Walmart Supercenters","url":"https://stock-news.laohu8.com/highlight/detail?id=2409122953","media":"StreetInsider","top":-1,"share":"https://ttm.financial/m/news/2409122953?lang=en_us&edition=fundamental","pubTime":"2024-02-07 21:31","pubTimestamp":1707312660,"startTime":"0","endTime":"0","summary":"Agreement is the first introduction of AI-driven epigenetic heart attack risk assessment and coronary heart disease detection tests in a retail healthcare setting on a walk-in basis.Cardio Diagnostics Holdings, Inc. , an AI-driven precision cardiovascular medicine company, today announced that the Company’s AI-driven epigenetic-genetic blood tests, Epi+Gen CHD and PrecisionCHD, will be available beginning Q2 2024 in a retail healthcare setting inside the Walmart Supercenter in Round Lake Beach, Illinois.Employees and customers in the Round Lake Beach Walmart location of FMS will have access to both of Cardio Diagnostics' clinical blood tests on a walk-in basis. The Company’s epigenetic-genetic cardiovascular clinical blood tests, Epi+Gen CHD and PrecisionCHD, detect heart attack risk and coronary heart disease status, respectively. These tests are easy to administer in the retail healthcare setting because they only require a simple blood draw, bringing this vital service closer to pat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.streetinsider.com/dr/news.php?id=22732762","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://cardiodiagnosticsinc.com","stockEarnings":[{"period":"1week","weight":0.1532},{"period":"1month","weight":-0.1854},{"period":"3month","weight":-0.5287},{"period":"6month","weight":-0.1525},{"period":"1year","weight":-0.4331},{"period":"ytd","weight":-0.6631}],"compareEarnings":[{"period":"1week","weight":0.0164},{"period":"1month","weight":0.05},{"period":"3month","weight":0.0584},{"period":"6month","weight":0.1728},{"period":"1year","weight":0.2732},{"period":"ytd","weight":0.1123}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.","exchange":"NASDAQ","name":"CARDIO DIAGNOSTICS HOLDINGS INC","nameEN":"CARDIO DIAGNOSTICS HOLDINGS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CARDIO DIAGNOSTICS HOLDINGS INC(CDIO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CARDIO DIAGNOSTICS HOLDINGS INC(CDIO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CARDIO DIAGNOSTICS HOLDINGS INC,CDIO,CARDIO DIAGNOSTICS HOLDINGS INC股票,CARDIO DIAGNOSTICS HOLDINGS INC股票老虎,CARDIO DIAGNOSTICS HOLDINGS INC股票老虎国际,CARDIO DIAGNOSTICS HOLDINGS INC行情,CARDIO DIAGNOSTICS HOLDINGS INC股票行情,CARDIO DIAGNOSTICS HOLDINGS INC股价,CARDIO DIAGNOSTICS HOLDINGS INC股市,CARDIO DIAGNOSTICS HOLDINGS INC股票价格,CARDIO DIAGNOSTICS HOLDINGS INC股票交易,CARDIO DIAGNOSTICS HOLDINGS INC股票购买,CARDIO DIAGNOSTICS HOLDINGS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CARDIO DIAGNOSTICS HOLDINGS INC(CDIO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CARDIO DIAGNOSTICS HOLDINGS INC(CDIO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction